DHX9 and hepatocellular carcinoma: In a similar vein, DHX9 can also mediate CDK6 downregulation, thereby supporting the helicase’s tumor suppressive functions that are compromised in hepatocellular carcinoma (HCC) due to the overexpressed long noncoding (lnc) RNA lnc-UCID.